Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Tax ProvisionsTax Rate
Others
Ratios

Qiagen (QGEN) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Qiagen (QGEN) over the last 17 years, with Q4 2025 value amounting to $200.2 million.

  • Qiagen's Cost of Revenue rose 1481.59% to $200.2 million in Q4 2025 from the same period last year, while for Dec 2025 it was $748.6 million, marking a year-over-year decrease of 2263.11%. This contributed to the annual value of $735.3 million for FY2025, which is 2279.22% down from last year.
  • Qiagen's Cost of Revenue amounted to $200.2 million in Q4 2025, which was up 1481.59% from $187.8 million recorded in Q3 2025.
  • In the past 5 years, Qiagen's Cost of Revenue ranged from a high of $461.6 million in Q2 2024 and a low of $151.7 million during Q1 2024
  • Over the past 5 years, Qiagen's median Cost of Revenue value was $178.0 million (recorded in 2021), while the average stood at $192.7 million.
  • In the last 5 years, Qiagen's Cost of Revenue skyrocketed by 17699.91% in 2024 and then plummeted by 5683.25% in 2025.
  • Quarter analysis of 5 years shows Qiagen's Cost of Revenue stood at $193.1 million in 2021, then fell by 14.33% to $165.5 million in 2022, then rose by 6.98% to $177.0 million in 2023, then decreased by 1.48% to $174.4 million in 2024, then grew by 14.82% to $200.2 million in 2025.
  • Its last three reported values are $200.2 million in Q4 2025, $187.8 million for Q3 2025, and $199.3 million during Q2 2025.